Madrigal Pharmaceuticals (MDGL) News Today $322.32 +5.17 (+1.63%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period 2,259 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Bought by F M Investments LLCF M Investments LLC purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 2,259 shares of the biopharmaceutical company's stock, valued at approximaApril 14 at 5:41 AM | marketbeat.comFmr LLC Raises Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Fmr LLC lifted its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 10.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 867,850 shares of the biopharmaceutical company's stock after purchaApril 14 at 4:32 AM | marketbeat.comRenaissance Technologies LLC Grows Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Renaissance Technologies LLC lifted its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 261.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 160,782 shares of the biopharmaceuApril 13 at 5:43 AM | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. cut its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 16.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 37,772 shares of the biopharmaceutical company's stock after selling 7,358 shares duringApril 12 at 4:29 AM | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Raised by Geode Capital Management LLCGeode Capital Management LLC increased its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 1.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 410,578 shares of the biopharmaceutical company's stock after purcApril 11 at 4:30 AM | marketbeat.comCapula Management Ltd Buys Shares of 1,148 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Capula Management Ltd purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,148 shares of the biopharmaApril 10, 2025 | marketbeat.comCalifornia Public Employees Retirement System Sells 985 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)California Public Employees Retirement System lowered its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 4.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,310 shares of the biopharApril 9, 2025 | marketbeat.com3,624 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Bought by Landscape Capital Management L.L.C.Landscape Capital Management L.L.C. bought a new stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,624 shares of the biopharmaceutical company's stock, valuApril 8, 2025 | marketbeat.comPrudential Financial Inc. Acquires 2,282 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Prudential Financial Inc. increased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 166.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,655 shares of the biopharmaceutiApril 8, 2025 | marketbeat.comCIBC Private Wealth Group LLC Decreases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)CIBC Private Wealth Group LLC decreased its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 66.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,050 shares of the biopharApril 7, 2025 | marketbeat.comSchroder Investment Management Group Trims Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Schroder Investment Management Group reduced its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 47.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,047 shares ofApril 7, 2025 | marketbeat.comNorges Bank Takes $35.51 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Norges Bank purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 115,092 shares of the biopharmaceutical company's stock, vApril 7, 2025 | marketbeat.comSei Investments Co. Sells 1,023 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Sei Investments Co. cut its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 11.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,229 shares of the biopharmaceuticaApril 6, 2025 | marketbeat.comBryce Point Capital LLC Buys Shares of 1,903 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Bryce Point Capital LLC purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,903 shares of the biopharmaceutical compaApril 5, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Purchased by Groupama Asset ManagmentGroupama Asset Managment raised its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 89.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 24,324 shares of the biopharmaceutical company'sApril 3, 2025 | marketbeat.comVanguard Group Inc. Sells 127,633 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Vanguard Group Inc. lowered its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,706,135 shares of the biopharApril 2, 2025 | marketbeat.comKLP Kapitalforvaltning AS Invests $802,000 in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)KLP Kapitalforvaltning AS purchased a new stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,600 shares of the biopharmaceutical company's stock, valued at aApril 2, 2025 | marketbeat.comPictet Asset Management Holding SA Buys 57,886 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Pictet Asset Management Holding SA boosted its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 38.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,484 shares ofMarch 31, 2025 | marketbeat.comNEOS Investment Management LLC Decreases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)NEOS Investment Management LLC lessened its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 27.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,620 shares of the biopharmaceuticaMarch 31, 2025 | marketbeat.comArtisan Partners Limited Partnership Trims Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Artisan Partners Limited Partnership cut its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 32.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 207,469 shares of the biopharmaceutical company'sMarch 29, 2025 | marketbeat.comAmerican Century Companies Inc. Grows Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)American Century Companies Inc. grew its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 22.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 136,849 shares of the biopharmaceutical coMarch 29, 2025 | marketbeat.comIs Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March?March 28, 2025 | insidermonkey.comKnights of Columbus Asset Advisors LLC Buys 2,116 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Knights of Columbus Asset Advisors LLC grew its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 82.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,695 shares oMarch 24, 2025 | marketbeat.comCibc World Markets Corp Makes New $519,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Cibc World Markets Corp purchased a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,681 shares of the biopharmaceuticaMarch 23, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating,March 23, 2025 | marketbeat.comMadrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to BillionairesMarch 18, 2025 | msn.comWilliam Blair Investment Management LLC Purchases Shares of 371,771 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)William Blair Investment Management LLC purchased a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 371,771 shares of the biopharmaMarch 18, 2025 | marketbeat.comRaymond James Financial Inc. Takes $16.62 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Raymond James Financial Inc. acquired a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 53,846 shares oMarch 18, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Has $2.43 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Skandinaviska Enskilda Banken AB publ lowered its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 12.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,798 shares of the bMarch 17, 2025 | marketbeat.comProficio Capital Partners LLC Acquires New Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Proficio Capital Partners LLC acquired a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 17,280 shares of the biopharmaceutical company's stock, valued atMarch 17, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $46.52 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Charles Schwab Investment Management Inc. boosted its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 150,746 shares of the biopharmaceutical company's stock after purchasing an additMarch 15, 2025 | marketbeat.comMadrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potentialMarch 14, 2025 | investing.comWintrust Investments LLC Purchases 900 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Wintrust Investments LLC grew its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 86.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,937 shares of the biopharmaMarch 14, 2025 | marketbeat.comMadrigal Pharmaceuticals Announces Changes to Board of DirectorsMarch 13, 2025 | msn.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Erste Asset Management GmbHErste Asset Management GmbH lessened its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 29.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 164,400 shares of the biopharmaceutical company's stock after selling 70,000 sharesMarch 13, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 43.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 103,288 shares of the biopMarch 13, 2025 | marketbeat.comMadrigal Pharmaceuticals management to meet with OppenheimerMarch 13, 2025 | markets.businessinsider.comDorsey & Whitney Trust CO LLC Makes New $257,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Dorsey & Whitney Trust CO LLC acquired a new stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 834 shares of the biopharmaceutical company's stock, valueMarch 12, 2025 | marketbeat.comVictory Capital Management Inc. Has $21.80 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Victory Capital Management Inc. boosted its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 2,981.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,635 shaMarch 12, 2025 | marketbeat.comMadrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of DirectorsMarch 11, 2025 | markets.businessinsider.comMadrigal Pharmaceuticals appoints Fouse to its board of directorsMarch 11, 2025 | markets.businessinsider.comMadrigal Appoints Jacqualyn A. Fouse, Ph.D.March 11, 2025 | globenewswire.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Robert E. Waltermire Sells 14,113 SharesMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) VP Robert E. Waltermire sold 14,113 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $341.32, for a total transaction of $4,817,049.16. Following the completion of the sale, the vice president now directly owns 3,728 shares of the company's stock, valued at approximately $1,272,440.96. This represents a 79.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.March 8, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Sells $4,817,049.16 in StockMarch 8, 2025 | insidertrades.comAigen Investment Management LP Purchases New Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Aigen Investment Management LP bought a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,771 shares of the biopharmaceutical company's stock, vMarch 7, 2025 | marketbeat.comTD Cowen Sticks to Their Buy Rating for Madrigal Pharmaceuticals (MDGL)March 6, 2025 | markets.businessinsider.comInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) VP Sells 1,227 Shares of StockMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) VP Robert E. Waltermire sold 1,227 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $341.07, for a total transaction of $418,492.89. Following the completion of the sale, the vice president now owns 3,728 shares in the company, valued at $1,271,508.96. This represents a 24.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.March 6, 2025 | marketbeat.comCarrera Capital Advisors Purchases New Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Carrera Capital Advisors acquired a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,243 shares of the biopharmaceutical comMarch 5, 2025 | marketbeat.comRobert E. Waltermire Sells 1,227 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockMarch 5, 2025 | insidertrades.comProficio Capital Partners LLC Takes $5.33 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Proficio Capital Partners LLC purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 17,280 shares of the biopharmaceutical company's stock, valued at approximMarch 4, 2025 | marketbeat.com Remove Ads Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼1.660.86▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼107▲MDGL Articles Average Week Remove Ads Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today United Therapeutics News Today Incyte News Today BioMarin Pharmaceutical News Today Exelixis News Today Neurocrine Biosciences News Today Exact Sciences News Today Halozyme Therapeutics News Today Repligen News Today Alkermes News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDGL Stock Free MDGL Stock Alerts